http://www.fpnotebook.com/
Vasomotor Symptoms of MenopauseAka: Hot Flashes, Hot Flushes, Flushing
- See Also
- Epidemiology
- Vasomotor symptoms occur in 85% of perimenopausal women
- Starts 1-2 years before Menopause
- Continues for up to 5 years
- Vasomotor symptoms occur in 85% of perimenopausal women
- Differential Diagnosis
- Medications
- Isoniazid
- Disulfiram reaction
- Niacin
- Hydralazine
- Calcitonin
- Aspirin sensitive
- Procardia
- Capsaicin
- MAO inhibitor when taken with Tyramine (beer, cheese)
- Medication withdrawal
- Clonidine
- Alpha-methyldopa
- Pheochromocytoma
- Carcinoid
- Mastocytosis in Leukemia
- Histamine and Prostaglandin D Release
- Hypotensive episodes
- Dermatographia
- VIP-oma or WDHA: Diarrhea, Hypokalemia, achlorhydria
- Menopausal flushing
- Emotional blushing
- Food and Environmental Stimuli
- Monosodium glutamate
- Thermal stimuli
- Ethanol (worse with Rosacea, Carcinoid, Mastocytosis)
- Scombroid Fish Poisoning: Tuna, Mahi-mahi, Mackerel
- Syndrome obscure in women
- Characteristics
- Telangiectasia
- Urticaria
- Flushing
- Peptic Ulcer Disease
- Diarrhea
- Increased blood and urine histamine
- Not associated with mastocytosis or Carcinoid
- Characteristics
- Medications
- Management: General
- Wear cool clothing
- Use a fan
- Drink cool liquids and eat cold foods
- Regular Exercise has mixed results
- Original study supported Exercise as effective
- Recent study does not show benefit in hot flushes
- Avoid Exacerbating food products
- Caffeine
- Alcohol in excess
- Spicy food
- Dietary fat intake
- Associated with hot flushes in postmenopause
- Riley (2004) J Gen Intern Med 19:740
- Vitamin Supplementation
- Vitamin B6 may be helpful
- Vitamin E is no more effective than Placebo
- Other measures associated with decreased symptoms
- Tobacco Cessation
- Yoga
- Massage
- Meditation
- Leisurely bath
- Weight loss
- Associated with less hot flushes in Perimenopause
- Riley (2004) J Gen Intern Med 19:740
- Management: Medications
- Estrogen Replacement Therapy
- Relieves symptoms in 80-90% of patients
- Progestin
- Progesterone transdermal cream (20 grams/day)
- Megestrol acetate (Megace) 20 mg PO bid
- Relieves symptoms ~50% of cases
- Medroxyprogesterone acetate (Provera) 20 mg orally daily
- Relieves symptoms ~50% of cases
- Clonidine 0.1 - 0.2 mg PO qhs (or transdermal patch)
- (1994) JCO 12:155
- Selective Serotonin Reuptake Inhibitors
- SSRIs shown to be effective
- Venlafaxine (Effexor)
- Dose: 12.5 mg orally twice daily or 75 mg orally at bedtime
- (1998) J Clin Oncol 16:2377
- Loprinzi (2000) Lancet 356:2059
- Paroxetine (Paxil CR) 12.5 to 25 mg PO qd
- Fluoxetine (Prozac)
- Venlafaxine (Effexor)
- SSRIs not found to be effective
- SSRIs shown to be effective
- Gabapentin (Neurontin) 300 mg PO tid
- Bellergal-S 100
- Small risk of addiction
- Aldomet 250 mg PO bid
- Estrogen Replacement Therapy
- Management: Herbals and Dietary Supplements
- Possible benefit
- Variable evidence for benefit
- Unlikely benefit
- Dong Quai (No better than Placebo)
- Evening Primrose Oil
- Red Clover
- Vitamin E slightly better than Placebo
- References
Flushing (C0016382) | |
|---|---|
| Definition (MSH) | A transient reddening of the face that may be due to fever, certain drugs, exertion, stress, or a disease process. |
| Definition (NCI) | A sudden reddening of the face. |
| Concepts | Sign or Symptom (T184) |
| ICD9 | 782.62 |
| MSH | D005483 |
| English | cutaneous vascular engorgement, Face goes red, FACIAL FLUSHING, Flush, Flushes, Flushing, flushing reaction, Flushings, SKIN FLUSHED, skin reddening |
| Spanish | enrojecimiento facial, rubor |
| Parent Concepts | Skin symptom (C0586407), [D]Pallor and flushing NOS (C0159038), Signs and Symptoms (C0037088), Integumentary System Signs and Symptoms (C1334192), Skin Diseases, Vascular (C0162819), Complexion changes (C0455815), Duplicate concept (C1274013) |
| Sources | AOD, COSTAR, CST, DXP, ICD9CM, MSH, MTH, NCI, NDFRT, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
